1. Home
  2. Analysis
  3. Transderm-scop
  4. Lopressor

Transderm scop and Lopressor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Transderm scop (scopolamine) and Lopressor (metoprolol tartrate). Common drug interactions include hyperkalaemia among females and agitation among males.

The phase IV clinical study analyzes what interactions people have when they take Transderm scop and Lopressor. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Transderm scop?

Transderm scop has active ingredients of scopolamine. It is often used in motion sickness. eHealthMe is studying from 3,011 Transderm scop users. Check the latest studies of Transderm scop.

What is Lopressor?

Lopressor has active ingredients of metoprolol tartrate. It is often used in high blood pressure. eHealthMe is studying from 33,152 Lopressor users. Check the latest studies of Lopressor.

On Jul, 04, 2026

14 people who take Transderm scop and Lopressor together, and have interactions are studied.

Transderm scop and Lopressor drug interactions.

What are the common drug interactions of Transderm Scop and Lopressor, by gender? *:

female:

  1. Hyperkalaemia (damage to or disease of the kidney)
  2. Nephrogenic anaemia (anaemia due to kidney disease)
  3. Abdominal pain upper
  4. Acute myocardial infarction (acute heart attack)
  5. Full blood count decreased
  6. Stomatitis (inflammation of mucous membrane of mouth)
  7. Vision blurred
  8. Acute respiratory failure
  9. Agitation (state of anxiety or nervous excitement)
  10. Anaemia (lack of blood)

male:

  1. Agitation (state of anxiety or nervous excitement)
  2. Hypoaesthesia (reduced sense of touch or sensation)
  3. Anxiety
  4. Aortic stenosis (obstruction to the outflow of blood from the left ventricle into the aorta)
  5. Aortic valve calcification
  6. Aphagia (inability or refusal to swallow)
  7. Apnoea (suspension of external breathing)
  8. Application site reaction
  9. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  10. Arthralgia (joint pain)

What are the common drug interactions of Transderm Scop and Lopressor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Chronic kidney disease
  2. Glomerulonephritis membranous (nephritis with inflammation of the capillary loops in the renal glomeruli)
  3. Hyperkalaemia (damage to or disease of the kidney)
  4. Lupus nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue)
  5. Nephrogenic anaemia (anaemia due to kidney disease)
  6. Nephropathy (damage to or disease of a kidney)
  7. Nephrotic syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema)
  8. Nocturia (the need to get up in the night to urinate)
  9. Proteinuria (presence of protein in the urine)
  10. Renal failure (kidney dysfunction)

30-39:

  1. Chronic kidney disease
  2. Hyperkalaemia (damage to or disease of the kidney)
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Renal failure (kidney dysfunction)

40-49:

n/a

50-59:

  1. Abdominal pain upper
  2. Acute myocardial infarction (acute heart attack)
  3. Dyspnoea (difficult or laboured respiration)
  4. Fatigue (feeling of tiredness)
  5. Full blood count decreased
  6. Nausea (feeling of having an urge to vomit)
  7. Pain
  8. Stomatitis (inflammation of mucous membrane of mouth)
  9. Vision blurred
  10. Application site reaction

60+:

  1. Agitation (state of anxiety or nervous excitement)
  2. Confusion
  3. Anaemia (lack of blood)
  4. Application site reaction
  5. Asthenia (weakness)
  6. Bladder dilatation
  7. Cardiac arrest
  8. Chest pain
  9. Confusional state
  10. Constipation

What are the existing conditions these people have? *

  1. Nausea (feeling of having an urge to vomit): 5 people, 35.71%
  2. Nausea And Vomiting: 3 people, 21.43%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 14.29%
  4. Delirium (wild excitement): 2 people, 14.29%
  5. Cough: 2 people, 14.29%
  6. High Blood Cholesterol: 1 person, 7.14%
  7. Encephalopathy (functioning of the brain is affected by some agent or condition): 1 person, 7.14%
  8. Dry Skin: 1 person, 7.14%
  9. Dehydration (dryness resulting from the removal of water): 1 person, 7.14%
  10. Stress And Anxiety: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Transderm scop and Lopressor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Transderm scop and Lopressor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Transderm scop:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lopressor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Transderm scop and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lopressor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on scopolamine and metoprolol tartrate (the active ingredients of Transderm scop and Lopressor, respectively), and Transderm scop and Lopressor (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.